CircRNAs and CNS Gene Transfer
CircRNAs and CNS Gene Transfer
批准号:
10158515
负责人:
Aravind Asokan
金额:
$37.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2022-04-30
关键词:
AffectAgeAnimal ModelAnimalsAntisense RNAAstrocytesBiogenesisBrainBrain regionC9ORF72Cell Culture TechniquesCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsCodeDataDetectionDevelopmentDiseaseDoseElementsEndoribonucleasesEngineeringExonsExonucleaseGene ExpressionGene Expression RegulationGene TransferGenesGenetic TranslationGrowth FactorHeartHepatotoxicityHumanIn VitroInsulinInternal Ribosome Entry SiteInverted Repeat SequencesLiverMediatingMicroRNAsMusNeurogliaNeurological ModelsNeuronal DifferentiationNeuronsOutcomePatientsPlasmidsPopulationPre-Clinical ModelProductionRNARNA ProcessingRNA SplicingRecombinant adeno-associated virus (rAAV)SafetySynapsesSystemTestingTherapeuticTissuesToxic effectTransaminasesTranslationsTreatment EfficacyUntranslated RNAWorkadeno-associated viral vectorbasecell agecell typecircular RNAdesignfrontotemporal lobar dementia-amyotrophic lateral sclerosisgene therapy clinical trialimprovedmRNA Stabilitymouse modelnervous system disorderneuron developmentneurotoxicneurotoxicitynovelnucleic acid-based therapeuticsoverexpressionprotein expressionpublic health relevanceresponsesmall hairpin RNAtherapeutic proteintime intervalvectorvector genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT: Circular RNAs (circRNAs) are an emerging class of RNA molecules with potential for prolonged expression due to their inaccessibility to exonucleases. Recent studies dissecting circRNA biogenesis have found inverted repeat sequences such as ALU repeats in humans, flanking a large number of exons that are subject to circularization and have shown these cis-elements as well as splicing machinery are essential for their circularization. In the mammalian brain, circRNAs appear to be highly abundant and dynamically regulated by development and plasticity. In particular, they appear to be enriched at the synapses and during neuronal differentiation and development. Despite these exciting advances, no systems for studying biogenesis of synthetic circRNAs in the brain and models of neurological disease. Specific aims for the current proposal are focused on engineering circRNA expression systems, studying factors affecting circRNA biogenesis efficiency in the brain, and utilizing these systems to interrogate deregulation of splicing and RNA-induced neurotoxicity seen in a C9orf72 Hexanucleotide Repeat Expansion mouse model of Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). CircRNAs capable of disrupting the neurotoxic RNA foci seen in these mouse models may enable design of therapeutics for FTD/ALS, where the C9orf72 expansion is prevalent and believed to be causative. Overall, the current proposal will help develop new strategies for efficient biogenesis of circRNAs in animal models, which are likely to help understand factors affecting circRNA biogenesis in the mammalian brain as well as usher in a new class of nucleic acid therapeutics based on circular RNAs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting AAV silencing in humanized mice
-
批准号:10562376
-
项目类别:
-
资助金额:$61.62万
-
财政年份:2023
-
负责人:Aravind Asokan
-
依托单位:
Engineering the biology of AAV secretion and production
-
批准号:10656028
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2023
-
负责人:Aravind Asokan
-
依托单位:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
-
批准号:10640060
-
项目类别:
-
资助金额:$97.19万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
-
批准号:10667569
-
项目类别:
-
资助金额:$47.71万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
-
批准号:10480356
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
-
批准号:10371617
-
项目类别:
-
资助金额:$98.54万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
-
批准号:10482406
-
项目类别:
-
资助金额:$115.87万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
RE-ENGINEERING AAV GENOME PACKAGING
-
批准号:9919589
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
-
批准号:10465740
-
项目类别:
-
资助金额:$83.36万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
CircRNAs and CNS Gene Transfer
-
批准号:9898485
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
Neutralizing Antibody & AAV FIX Gene Therapy
-
批准号:8990027
-
项目类别:
-
资助金额:$230.58万
-
财政年份:2013
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7822438
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2009
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7871991
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2009
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7583075
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7749567
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Tropism
-
批准号:8785694
-
项目类别:
-
资助金额:$44.93万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:8197206
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Tropism
-
批准号:10198986
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Tropism
-
批准号:8577188
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:8386661
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: